Tricuspid Regurgitation Study

PHASE4CompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

September 30, 2015

Study Completion Date

May 31, 2016

Conditions
Tricuspid RegurgitationRight Ventricular DysfunctionLeft Ventricular Dysfunction
Interventions
OTHER

Echo

Two dimensional echocardiography will be performed to reassess Tricuspid Regurgitation.

OTHER

Echo

Two dimensional echocardiography will be performed to reassess Tricuspid Regurgitation

OTHER

Echo

Two dimensional echocardiography will be performed to reassess Tricuspid Regurgitation.

OTHER

Echo

Two dimensional echocardiography will be performed to reassess Tricuspid Regurgitation.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Abbott Medical Devices

INDUSTRY

lead

Mayo Clinic

OTHER